OR WAIT null SECS
January 27, 2016
Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.
January 14, 2016
FDA issued a warning letter to Zhejiang Hisun Pharmaceutical Co., Ltd., as a result of inspections that took place on March 2–7, 2015 at the Taizhou City, Zhejiang Province, API manufacturing facility.
January 02, 2016
Nanoscale catalysts and engineered nanoparticles may have a big impact on small-molecule pharmaceuticals.
FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.
December 30, 2015
BASF and Sumitomo Chemical explore in vitro system for chemical safety evaluation.
December 14, 2015
Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions.
December 02, 2015
A strong API market is expected in 2016 despite fewer new drug approvals.
November 30, 2015
The ReactoMate Datum controlled lab reactor system accommodates a range of vessel sizes.
Multi-component coupling reactions for the generation of heterocycles in fewer steps reduced processing times, cost, and waste are attracting interest.
November 26, 2015
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.